391 related articles for article (PubMed ID: 15844501)
21. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
[TBL] [Abstract][Full Text] [Related]
22. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
23. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
24. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.
Lennox PA; Hitchings AE; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):71-4. PubMed ID: 15794078
[TBL] [Abstract][Full Text] [Related]
25. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
Hitchings AE; Lennox PA; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
[TBL] [Abstract][Full Text] [Related]
26. External beam radiotherapy for severe epistaxis from Osler-Weber-Rendu disease.
Harwood AR; Wojak JC; Barry R
J La State Med Soc; 2002; 154(3):154-5. PubMed ID: 12139363
[TBL] [Abstract][Full Text] [Related]
27. [Recurrent nosebleeds in patients with hereditary hemorrhagic telangiectasia].
Slotosch D; Koller M; Werner JA; Folz BJ
Dtsch Med Wochenschr; 2006 Mar; 131(11):535-9. PubMed ID: 16538555
[TBL] [Abstract][Full Text] [Related]
28. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Harvey RJ; Kanagalingam J; Lund VJ
Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
[TBL] [Abstract][Full Text] [Related]
30. Clinical strategy in hereditary hemorrhagic telangiectasia.
Kühnel TS; Wagner BH; Schurr CP; Strutz J
Am J Rhinol; 2005; 19(5):508-13. PubMed ID: 16270607
[TBL] [Abstract][Full Text] [Related]
31. Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia.
Silva BM; Hosman AE; Devlin HL; Shovlin CL
Laryngoscope; 2013 May; 123(5):1092-9. PubMed ID: 23404156
[TBL] [Abstract][Full Text] [Related]
32. [Our experience on Rendu-Osler disease. Apropos of 19 cases].
Seidermann L; Mérol JC; Nasser T; Swierkosz F; Legros M
Rev Laryngol Otol Rhinol (Bord); 1996; 117(5):367-72. PubMed ID: 9183908
[TBL] [Abstract][Full Text] [Related]
33. [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Sadick H; Riedel F; Oulmi J; Hörmann K; Bergler WF
HNO; 2003 Feb; 51(2):118-24. PubMed ID: 12589417
[TBL] [Abstract][Full Text] [Related]
34. A natural obturator in hereditary haemorrhagic telangiectasia.
Soni-Jaiswal A; Woolford TJ
J Laryngol Otol; 2009 Jun; 123(6):695-6. PubMed ID: 19275781
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.
Kjeldsen AD; Kjeldsen J
Am J Gastroenterol; 2000 Feb; 95(2):415-8. PubMed ID: 10685743
[TBL] [Abstract][Full Text] [Related]
36. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
[TBL] [Abstract][Full Text] [Related]
37. [Osler--Rendu Disease: an example of a family clustering in a genetic disorder].
Mitu F; Lovin S; Rusu C; Mitu M; Georgescu T; Pandele GI; Covic M
Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):820-4. PubMed ID: 14974237
[TBL] [Abstract][Full Text] [Related]
38. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
[TBL] [Abstract][Full Text] [Related]
39. [Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) as an example of a rare disease relevant for oto-rhino-laryngology].
Geisthoff UW; Maune S; Schneider G
Laryngorhinootologie; 2011 Apr; 90(4):230-42; quiz 243-4. PubMed ID: 21523625
[TBL] [Abstract][Full Text] [Related]
40. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
